华中科技大学学报(医学版) ›› 2026, Vol. 55 ›› Issue (2): 251-257.doi: 10.3870/j.issn.1672-0741.25.05.006

• 临床研究 • 上一篇    下一篇

急性心肌梗死患者血浆细胞外囊泡miRNA分子标记物的筛选与验证*

乔素冬1,3#, 苗长青2#, 王怡春1, 徐若琛2, 张桢2, 马一诺4, 刘铮4, 孙振威1△, 贾竟2△   

  1. 1河南省中医院(河南中医药大学第二附属医院)检验中心,郑州 450002
    2郑州大学 基础医学院 ,郑州 450001
    3联勤保障部队第988医院检验输血科,郑州 450042
    4郑州大学第一临床学院,郑州 450001
  • 出版日期:2026-04-15 发布日期:2026-04-16
  • 通讯作者: E-mail:study1985117@126.com(孙振威);jiajing@zzu.edu.cn(贾 竟)
  • 作者简介:#共同第一作者. 乔素冬,女,1988年,硕士研究生,主管技师,E-mail:Qsudong@126.com; 苗长青,男,2000年,硕士研究生,E-mail:cq_miao0430@163.com
  • 基金资助:
    *河南省医学科技攻关计划联合共建项目(No.LHGJ20220918)

Plasma Extracellular Vesicle miRNAs as Potential Biomarkers for Acute Myocardial Infarction

Qiao Sudong1,3#, Miao Changqing2#, Wang Yichun1 et al   

  1. 1Laboratory Center of Henan Province Hospital of Traditional Chinese Medicine, The Second Affiliated Hospital of Henan University of Chinese Medicine,Zhengzhou 450002,China
    2School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China
    3Laboratory and Transfusion Medicine,No.988 Hospital of Joint Logistic Support Force,Zhengzhou 450042,China
    4First Clinical Medical College,Zhengzhou University,Zhengzhou 450001,China
  • Online:2026-04-15 Published:2026-04-16
  • Contact: E-mail:study1985117@126.com;jiajing@zzu.edu.cn

摘要: 目的 筛选急性心肌梗死(acute myocardial infarction,AMI)患者血浆中的细胞外囊泡微小RNA(EV-miRNA)诊断标记物并探讨其临床价值。方法 收集3例AMI患者及3例健康对照者的血浆样品,分别提取其血浆miRNA进行测序,并提取细胞外囊泡miRNA进行EV-miRNA测序。通过生物信息学分析,筛选出与AMI显著相关的EV-miRNA分子标记物;随后,再收集27例AMI患者及25例健康对照者的血浆样品,通过qRT-PCR验证筛选出的差异表达EV-miRNA。使用ROC曲线分析评估EV-miRNA对AMI的诊断效能。将筛选出的miRNA进行靶基因预测并分析其与临床指标的相关性。结果 与健康对照组相比,AMI患者血浆细胞外囊泡中miR-6809-3p、miR-3938、miR-6815-5p、miR-4322、miR-6717-5p和miR-6797-5p的表达水平升高,差异有统计学意义(均P<0.05);miR-6815-5p、miR-4322和miR-6717-5p的曲线下面积(AUC)值均超过0.9,显示出对AMI较高的诊断价值。肌酸激酶同工酶MB与miRNA-4322的表达呈弱相关。结论 血浆EV-miRNA可作为AMI诊断的潜在分子标记物。

关键词: 急性心肌梗死, 细胞外囊泡, 微小RNA, 分子标记物

Abstract: Objective To identify diagnostic biomarkers of plasma extracellular vesicle microRNAs(EV-miRNAs)for acute myocardial infarction(AMI)and to investigate their clinical diagnostic significance. Methods Plasma samples were obtained from three AMI patients and three healthy controls.miRNAs were extracted from both plasma and extracellular vesicles and subsequently subjected to sequencing to establish EV-miRNA profiles.Bioinformatics analysis was performed to select EV-miRNAs significantly associated with AMI.Validation plasma samples were collected from 27 AMI patients and 25 healthy controls for qRT-PCR analysis of the screened differentially expressed EV-miRNAs.The diagnostic performance of AMI-predictive EV-miRNAs was evaluated using ROC curve analysis.Target genes of the selected miRNAs were correlated with clinical indicators. Results Compared with the healthy control group,the expression levels of miR-6809-3p,miR-3938,miR-6815-5p,miR-4322,miR-6717-5p,and miR-6797-5p were significantly elevated in peripheral blood extracellular vesicles of the AMI group(all P<0.05).The area under the ROC curve(AUC)for miR-6815-5p,miR-4322,and miR-6717-5p exceeded 0.9,indicating high diagnostic potential.Furthermore,the expression of creatine kinase MB isoenzyme exhibited a weak positive correlation with miRNA-4322. Conclusion Plasma extracellular vesicle miRNAs may serve as potential molecular biomarkers for AMI diagnosis,providing novel insights for the identification of therapeutic molecular targets for AMI.

Key words: acute myocardial infarction, extracellular vesicles, miRNA, biomarker

中图分类号: